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Abstract
Background The aseptic lymphocyte vasculitis-associ-
ated lesion (ALVAL) score and the modified Oxford
ALVAL score are frequently used scoring methods to
evaluate the morphologic features of periprosthetic tissues
around metal-on-metal (MoM) hip implants. Except for the
initial studies of these two morphology scoring methods, to
our knowledge, no other studies have reported on intraclass
correlation coefficient (ICC) values for interobserver reli-
ability of these scoring methods.
Questions/purposes Are the ALVAL and Oxford
ALVAL scores reproducible?
Methods The periprosthetic tissue of 37 revisions of 36
patients with failed MoM THAs were independently scored
by three experienced pathologists using ALVAL and
Oxford ALVAL scoring methods. All patients were
included who underwent revision surgery in our hospital
until January 2013, with a large-head MoM prosthesis and
also met the criteria: blood serum cobalt levels, available
MRI scan, and intraarticular cobalt levels. The population
included 26 patients with pseudotumors diagnosed by two
radiologists using the method described by Matthies et al.
The ALVAL describes morphologic features of the syn-
ovial lining, tissue organization, and inflammatory cell
infiltrate in periprosthetic tissues. The Oxford-ALVAL
score uses a semiquantitative measure of the immune
response which should be easier to score.
Results The ALVAL score showed an ICC of 0.38 (95%
CI, 0.18–0.58) (fair) for the sum score and this improved
up to 0.50 (95% CI, 0.31–0.68) (moderate) using the
modified Oxford ALVAL score. The individual parameters
of the ALVAL score showed an ICC for the scoring of
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inflammatory infiltrate of 0.37 (95% CI, 0.17–0.57), an
ICC of 0.32 (95% CI, 0.12–0.53) for the scoring of tissue
organization, and an ICC of 0.14 (95% CI, 0.04 to 0.34)
for synovial lining.
Conclusions Scoring morphologic features of MoM tis-
sue is not reproducible using the ALVAL score or the
Oxford ALVAL score. This may reflect heterogeneous
morphologic features in tumor tissue and between different
tumor tissue samples that cannot be reliably quantified by
pathologists using the parameters of these two scoring
methods. An alternative, simplified scoring system should
be developed to improve the interrater agreement.
Level of Evidence Level III, diagnostic study.
Introduction
Despite hopes that metal-on-metal (MoM) bearings would
provide long-lasting pain relief and restoration of function
in THAs, revision rates for many designs have been
alarmingly high. Release of metal ions and particles from
the MoM bearing leads to elevated high local and systemic
exposure to cobalt and chromium ion levels. At the local
level, pseudotumor is a frequent finding, described as
development of a cystic solid mass in the periarticular
region, which has a direct communication with the joint
[14]. A possible explanation for the occurrence of pseu-
dotumors and failure of the MoM THA is the toxicity of the
local metal debris rich in cobalt particles that can induce
DNA damage and cell death, which occurs either by dis-
ruption of the membrane or because of the DNA damage.
An inflammatory mass develops in response to the
cytokines released [10]. Although pseudotumors also are
seen in patients after conventional THA with ceramic-on-
polyethylene [3] and are described in case reports of metal-
on-polyethylene [17, 21], risk for development of these
pseudotumors is increased in patients with elevated serum
metal ion levels [4].
Aseptic lymphocyte vasculitis-associated lesion
(ALVAL), first reported by Davies et al. [8], is a histologic
description made from tissue sampling at the time of sur-
gery identifying an abundance of lymphocytes in the local
pericapsular tissue. ALVAL typically is associated with
local metal ion release. A meta-analysis showed a pooled
estimate of the incidence of pseudotumor or ALVAL in
MoM hip articulations to be 0.6% [30], and another study
showed up to 6.5% ALVAL [16]. The most-used descrip-
tion method of periprosthetic tissues around MoM hip
implants is the ALVAL score of Campbell et al. [7]. This
subsequently was modified by Grammatopoulos et al. [12],
(herein referred to as the Oxford ALVAL) to be able to
distinguish if the inflammatory changes and tissue necrosis
seen in periprosthetic tissues around failed MoM hip
resurfacing implants are attributable to cytotoxicity or
hypersensitivity tissue necrosis, and the extent of the
inflammatory cell infiltrate was included. Both scoring
systems are widely used [6, 9, 15, 22–24, 26, 27], however
to our knowledge, other than the initial studies [7, 12], no
other studies have reported on interrater reliability. Thus, it
is unclear if these scoring instruments are reproducible.
We therefore asked whether the ALVAL and Oxford
ALVAL scores were reproducible.
Patients and Methods
Between February 2008 and January 2011, a series of 377
uncemented primary MoM THAs with a M2a-38TM and
Taperloc1 stem combination (Biomet, Warsaw, IN, USA)
were performed at the Meander Medical Centre. During
that period, we used this implant when there was an indi-
cation for a THA. Of the patients who were treated with
this approach, nine patients (3%) had died, three (1%) were
lost to followup, and four (1%) underwent revision surgery
before the screening protocol (two infections, one
periprosthetic fracture, and one because of pain and sub-
luxations). Three hundred thirty-five patients (361 hips;
95%) were available for followup at a minimum of 11
months (mean, 30 months; range, 11–58 months) [28].
After the first concerns of MoM THA and an alert issued
by the Dutch Orthopaedic Association, all patients were
subjected to a screening protocol. For the current study,
patients who underwent revision surgery because of failure
of their MoM hip prostheses were included. A total of 71
revisions were performed in 70 patients. Twenty revisions
were not MoM related. Fifty-one revisions were related to
MoM problems. Of these, 36 patients with 37 revisions
(one bilateral) were selected for the current study because
tissue samples, intraarticular cobalt values, and MR images
were available. One patient had bilateral MoM THA and
underwent revision on both sides; 10 patients had bilateral
MoM THAs and underwent revision on one side; and all
other patients underwent revision on their unilateral MoM
THA. The mean age of the patients at primary surgery was
62 years (SD, 8.2 years); 29 patients were women. The
main reason for primary surgery was osteoarthritis
(Table 1). The mean serum cobalt level was 20 lg/L (SD,
33 lg/L) and the mean intraarticular fluid cobalt was 2240
lg/L (SD, 2689 lg/L) (Table 1). Pain was reported by 28
patients (76%).
Twenty-six pseudotumors were diagnosed on MRI.
Most of the pseudotumors were described as 2A according
to the classification described by Matthies et al. [18] (n =
24). Two Type 3 pseudotumors were diagnosed (Table 1).
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Reasons for revision were pseudotumor formation in
combination with pain and elevated serum levels of cobalt
or pain and elevated serum cobalt levels without pseudo-
tumor formation and failure of the hip for other reasons
(acetabular loosening [n = 2] and component impingent [n
= 1]; these patients also had elevated cobalt levels). During
revision surgery two to three samples were taken by the
surgeon of the spots which were macroscopically affected
by MoM disease. Each sample was formalin-fixed, paraf-
fin-embedded, and sectioned. Slides were stained with
standard hematoxylin and eosin. Sample slides (three to
four for each patient) were independently examined by
three pathologists (AHGC, RWR, SVD) who were expe-
rienced in diagnosing skeletal and soft tissue related
diseases, and thus well trained in recognizing different
types of inflammation cells and patterns of inflammation.
These pathologists independently evaluated the tissue
samples using the ALVAL score [7] and the adapted
Oxford ALVAL scoring method [12]. The total scores of
each pathologist are shown in a supplemental appendix
(Appendix 1. Supplemental materials are available with the
online version of CORR1.) that shows the distribution of
low, moderate, or high ALVAL scores were comparable
among the pathologists. The slides were scored with the
ALVAL score as described by Campbell et al. [7] and the
modifications of the Oxford ALVAL by Grammatopoulos
et al. [12] (Table 2). All three pathologists were blinded to
the clinical outcome. The intraclass correlation coefficient
(ICC) was obtained from the individual parameter scores.
The scientific committee of the Leiden University
Medical Centre and the ethical committee in the Meander
Medical Centre waived approval for the human protocol
for this investigation, because the removed tissue was sent
for routine histopathologic analysis. Because revision sur-
gery had to be performed at such a short followup and
because scientific concerns were present regarding the
tissue reactions potentially caused by the MoM articula-
tion, performing a histopathologic analysis was considered
part of good clinical practice.
During the outpatient clinic visit, patients answered a
standard clinical questionnaire (pain: yes or no) and
underwent a physical examination. Blood samples were
collected in a metal-free container. Serum cobalt was
determined with the use of an AanalystTM 800 Atomic
Absorption Spectrophotometer (PerkinElmer, Waltham,
MA, USA). Cobalt serum levels between 0.04 and 0.64 lg/
L were considered normal in the general population [11].
In case of revision surgery, a sample of the intraarticular
fluid was taken and the cobalt values of the fluid were
determined using the AAnalystTM 800 Atomic Absorption
Spectrophotometer.
A contrast-enhanced MRI of the hip region with metal
artifact reducing sequences (MARS) was performed on
patients with osteolysis observed on the radiograph, ele-
vated cobalt levels greater than 5 lg/L (cutoff value in
patients with a MoM implant [13]), or with pain. Pain was
defined as either the presence or absence of any pain in the
hip area reported by the patient. Patients who met these
criteria received routine annual followup. A 1.5-T MRI
unit (Achieva; Philips Healthcare, Best, The Netherlands)
was used to obtain the MARS sequences. As a contrast
agent, Dotarem1 (Guerbet, Paris, France) was used.
All MRI scans were evaluated by a senior muscu-
loskeletal radiologist (MN) and a resident in radiology
(BS) with expertise in musculoskeletal disease. The criteria
of the Anderson et al. [2], Hauptfleisch et al. [14], and
Matthies et al. [18] classifications were used. These criteria
were periprosthetic soft tissue mass or fluid-filled
periprosthetic cavities and their diameter; the thickness and
regularity of the wall; muscle atrophy; edema or bone
marrow edema, and tendon avulsion or fracture of the
bone. The classification of Anderson et al. [2] is based on
their experience regarding how the MRI appeared to
influence management of patients with a pseudotumor. The
classifications of Matthies et al. [18] and Hauptfleisch et al.
[14] are based on radiologic findings to classify the pseu-
dotumor. In the results, the classification of Matthies et al
[18] was used to describe the findings because it provided
the best ICC (0.49) in our cohort.
Table 1. Clinical data
Demographics Mean (SD)




BMI (kg/m2) 28 (4)
Time until revision surgery (months) 36 (9)
Reasons for surgery
Osteoarthritis 33 (89%)
Secondary osteoarthritis 3 (8%)
Necrosis of the femoral head 1 (3%)
Serum cobalt (lg/L) 20 (33)
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The original ALVAL scoring system described by
Campbell et al. [7] uses three different histologic criteria:
synovial lining, inflammatory infiltrate, and tissue organi-
zation, which add up to an overall score. The modified
Oxford ALVAL scoring system described by Gram-
matopoulos et al. [12] adds tissue necrosis and the extent of
the inflammatory cell infiltrate in the periprosthetic tissues.
The presence of specific inflammatory cells (macrophages,
lymphocytes, plasma cells, eosinophil polymorphs) is
noted and the ALVAL response is rated semiquantitatively
(Table 2).
Statistical Analysis
Descriptive analyses were performed on final outcomes.
The results are expressed as means with SD or medians
with ranges where relevant.
The interobserver reliability was calculated as an ICC
with a 95% CI based on a two-way random-ANOVA with
patient and pathologist as random factors for three
pathologists. This ICC has an interpretation as a weighted
kappa with quadratic weights.
Table 2. Scoring of the histologic findings
Scoring Points
Synovial lining (ALVAL)
Intact synovial lining 0
Focal loss of synovial surface, fibrin attachment may occur 1
Moderate to marked loss of synovial surface, fibrin attachment 2
Complete loss of synovium, abundant attached fibrin and/or necrosis of lining tissue 3
Inflammatory infiltrate (ALVAL)
Minimal inflammatory cell infiltrates 0
Predominantly macrophages, occasional lymphocytes may occur 1
Mix of macrophages and lymphocytes, either diffuse and/or small (\ 50% of hpf) perivascular aggregates 2
Mix of macrophages and lymphocytes, large ([ 50% hpf) perivascular aggregates may occur 3
Predominantly lymphocytes, mostly in multiple, large ([ 50% hpf) perivascular aggregates, follicles may be present 4
Tissue organization (ALVAL)
Normal tissue arrangement 0
Mostly normal tissue arrangement, small areas of synovial hyperplasia, focal necrosis may occur 1
Marked loss of normal arrangement, appearance of distinct cellular and acellular zones, thick fibrous layers may occur 2
Perivascular lymphocytic aggregates mostly located distally, thick acellular areas may occur 3







Scattered small necrotic areas 1+
Frequent small or large necrotic areas with up to 25% tissue involvement 2+
Extensive necrosis with[ 25% tissue necrosis 3+
Oxford ALVAL score (semiquantitative score)
No evidence of a perivascular lymphocyte infiltrate 0
Little evidence of a perivascular lymphocytic infiltrate with lymphocyte cuffing of blood vessels being fewer than five cells in thickness 1
Several perivascular lymphoid aggregates with lymphocyte cuffing of vessels being five to 10 cells in thickness 2
Numerous large perivascular lymphoid aggregates with lymphocyte cuffing around vessels being more than 10 cells in thickness 3
The original ALVAL score [7] uses the first three categories (synovial lining, inflammatory infiltrate, and tissue organization); the Oxford scoring
system [12] assesses tissue necrosis and the extent of the inflammatory cell infiltrate in the periprosthetic tissues. The presence of specific
inflammatory cells (macrophages, lymphocytes, plasma cells, eosinophil polymorphs) was noted, and the presence or absence of an ALVAL
response was assessed semiquantitatively as previously described. In the current study all parameters are scored; the number of specific
inflammatory cells is scored as 0 (absent), 1 (few), 2 (many), or 3 (abundant). Necrosis was scored as 0 (absent), 1 (scattered small necrotic
areas), 2 (frequent small or large necrotic areas with up to 25% tissue involvement), or 3 (extensive necrosis with[25% tissue involvement);
ALVAL = aseptic lymphocyte vasculitis-associated lesion; hpf = high-power field.
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The ICC value for agreement was interpreted as follows:
poor \ 0.20; fair, 0.21 to 0.40; moderate, 0.41 to 0.60;
good, 0.61 to 0.80; and very good, 0.81 to 1.0 [5]. SPSS
Statistics Version 20.0 (IBM Corporation, Armonk, NY,
USA) was used for the analysis.
Results
The ICC for the sum score using the ALVAL classification
is 0.38 (95% CI, 0.18–0.58), which is categorized as fair.
The individual parameters of this score show an ICC for
the scoring of inflammatory infiltrate of 0.37 (95% CI,
0.17–0.57), an ICC of 0.32 (95% CI, 0.12–0.53) for the
scoring of tissue organization, and an ICC of 0.12 (95% CI,
0.00–0.34) for synovial lining (Table 3). The ICC for the
sum score using the Oxford ALVAL score is 0.50 (95% CI,
0.30–0.68), which is categorized as moderate. The scoring
of inflammatory cells and necrosis showed ICC between
0.04 (95% CI, 0.00–0.24) and 0.50 (95% CI, 0.29–0.68).
The highest ICC, 0.50 (95% CI, 0.29–0.68) was found for
inflammatory cells (lymphocytes) (Table 3). Heteroge-
neous morphologic features in a discordant case with no
dense lymphocytic infiltrate and areas with no intact syn-
ovial lining with fibrin attachment (Fig. 1) and in a
discordant case with dense perivascular lymphocytic
aggregates (Fig. 2) are shown.
Discussion
MoM THAs have a high failure rate [29]. Elevated serum
cobalt levels, pseudotumors, and tissue reaction have been
described [13, 14, 31]. Pathologic findings in patients with
failed MoM THAs have been described using the ALVAL
and Oxford ALVAL scoring methods [7, 12]. Only the
initial studies [7, 12] report ICC values for interobserver
reliability. In the current study, we tested the repro-
ducibility of these scoring systems by three independent
pathologists. The scoring system of Campbell et al. [7]
showed an ICC of 0.38 (95% CI, 0.18–0.58) for the sum
score, which is rated as fair. The sum score improved up to
0.5 (95% CI, 0.30–0.68) using the modified Oxford
ALVAL score [12].
This study had several limitations. Only one type of
implant was used, which might not be characteristic of
other MoM devices. The selection for revision surgery was
made by using the described screening method. All patients
who underwent revision surgery were symptomatic and
most of the patients had high cobalt serum levels. Thus, our
findings may not be applicable to patients with different
Table 3. Intraclass correlation coefficients of the morphologic fea-
tures of the scoring
Morphologic features Intraclass correlation (95%
CI)
Synovial lining 0.12 (0.00–0.34)
Inflammatory infiltrate 0.37 (0.17–0.57)
Tissue organization 0.32 (0.12–0.53)
Sum score 0.38 (0.18–0.58)
Inflammatory cells (macrophages) 0.44 (0.24–0.64)
Inflammatory cells (lymphocytes) 0.50 (0.29–0.68)





Oxford ALVAL score 0.50 (0.30–0.68)
ALVAL = aseptic lymphocyte vasculitis-associated lesion.
Fig. 1A–B Histologic analyses of hematoxylin and eosin-stained
sections at (A) 92.5 magnification and (B) 910 magnification show
the morphologic spectrum in discordant cases with no dense
lymphocytic infiltrate and areas with no intact synovial lining with
fibrin attachment (black arrows).
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presentations, such as asymptomatic patients with con-
cerning MRI and laboratory findings. No prelearning
meeting with all three pathologists was done to describe
how to score the tissue slides using the scoring methods.
Nevertheless all pathologists are experienced in diagnosing
skeletal and soft tissue-related diseases, and thus well
trained in recognizing different types of inflammation cells
and patterns of inflammation. We believe that the poor
ICCs we found in our study regarding the ALVAL and
Oxford ALVAL scores are attributable to the complex, and
therefore not reproducible, scoring methods rather than
expert level of individual pathologists. We had a relatively
small sample size, meaning that we might not have
detected a truly high level of reliability. However, the
studies reporting the original ALVAL [7] and Oxford
ALVAL [12] scores were based on 32 and 65 samples,
respectively.
Although the modified classification system improves
the ICC value, it is still no more than moderate. A mod-
erate score indicates inadequate interrater agreement and
study results are not reliable to draw any definitive con-
clusions [5, 19]. Our low ICC values for the individual
parameters (inflammatory cells and necrosis) varying
between 0.04 and 0.50 underline the low reproducibility of
these morphologic findings. In contrast to our results,
Campbell et al. [7] reported an interrater reliability of 0.71
and Grammatopoulos et al. [12] reported interrater relia-
bility of 0.74. The ICCs of the ALVAL and the Oxford
ALVAL was scored by two observers in these original
studies.
Despite that the ALVAL and Oxford ALVAL scoring
methods are not well validated, these scoring systems were
used in other studies without reporting ICC values [6, 9, 15,
22_24, 26, 27]. These study results should be interpreted
with caution. Our results clearly illustrate that the ALVAL
and Oxford ALVAL scoring systems are not reproducible
in our hands, and therefore we believe that clinicians
should not use these scoring methods. Larger cohorts are
required for the development of an alternative, more-sim-
plified scoring method. Multiple pathologists should score
a set of cases to investigate how well the new scoring
method is reproducible. Digital imaging analysis showed
good results in liver fibrosis [25], in assessing digital ulcers
in patients with systemic sclerosis [1], and in analysis of
cancer stem cell marker expression [20]. This type of tissue
analysis might be a good alternative for scoring of MoM
periprosthetic tissue.
If this scoring method is reproducible, correlation with
clinically meaningful data should be performed.
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